20 May 2013
Keywords: intercell, ixiaro, je, vacc, recommended, eu, approval
Article | 08 April 2009
US biotechnology firm Epix Pharmaceuticals has sold the US, Canadian and Australian rights for its blood pool magnetic resonance angiography
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 April 2009
3 April 2009
6 April 2009
© 2013 thepharmaletter.com